Incentive takeover moves closer as Gambro posts solid results
This article was originally published in Clinica
Executive Summary
As Gambro revealed healthy results for 1995, the company's board recommended that shareholders accept Incentive's offer to take full control of the Swedish medtech group. Incentive acquired 49.4% of Gambro's share capital and 73.5% of its voting rights on January 2nd (see Clinica No 687, p 1). Shareholders have until the end of February to decide whether to sell their stake to Incentive at a price of SKr 155 per B share.